Home/Filings/4/0001683168-23-002495
4//SEC Filing

Downs Christopher 4

Accession 0001683168-23-002495

CIK 0001729427other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 8:00 AM ET

Size

4.5 KB

Accession

0001683168-23-002495

Insider Transaction Report

Form 4
Period: 2023-04-17
Downs Christopher
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-04-17$3.20/sh+3,100$9,9209,251 total

Documents

1 file

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1
  • filerCIK 0001705978

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 8:00 AM ET
Size
4.5 KB